These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1706512

  • 1. AgNOR staining in benign hyperplasia and carcinoma of the prostate.
    Mamaeva S, Lundgren R, Elfving P, Limon J, Mandahl N, Mamaev N, Henrikson H, Heim S, Mitelman F.
    Prostate; 1991; 18(2):155-62. PubMed ID: 1706512
    [Abstract] [Full Text] [Related]

  • 2. Nucleolar organizer regions (NOR) in hyperplastic and neoplastic prostate disease.
    Deschênes J, Weidner N.
    Am J Surg Pathol; 1990 Dec; 14(12):1148-55. PubMed ID: 2252105
    [Abstract] [Full Text] [Related]

  • 3. Nucleolar organiser regions in hyperplastic and neoplastic prostatic tissue.
    Hansen AB, Ostergård B.
    Virchows Arch A Pathol Anat Histopathol; 1990 Dec; 417(1):9-13. PubMed ID: 1694333
    [Abstract] [Full Text] [Related]

  • 4. Silver-binding nucleolar organizer regions in benign and malignant prostatic lesions.
    Pavlakis K, Alivizatos G, Mitropoulos D, Constantinides C, Skopelitou A, Kittas C, Dimopoulos C.
    Urol Int; 1992 Dec; 49(3):137-40. PubMed ID: 1281586
    [Abstract] [Full Text] [Related]

  • 5. Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF.
    Sakr WA, Sarkar FH, Sreepathi P, Drozdowicz S, Crissman JD.
    Prostate; 1993 Dec; 22(2):147-54. PubMed ID: 7681206
    [Abstract] [Full Text] [Related]

  • 6. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
    Helpap B, Riede C.
    Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
    [Abstract] [Full Text] [Related]

  • 7. [Correlation between the nucleolar organizer region in adenocarcinoma of the prostate and the Gleason system].
    Sentinelli S, Pizzuti V, Rondanelli E, Viggiani F, Paolini R.
    Pathologica; 1992 Jun; 84(1089):49-55. PubMed ID: 1379709
    [Abstract] [Full Text] [Related]

  • 8. Silver staining nucleolar organizer region in prostate cytology.
    Bittinger A, von Keitz A, Rüschoff J, Melekos MD.
    Zentralbl Pathol; 1994 Mar; 140(1):103-6. PubMed ID: 7515666
    [Abstract] [Full Text] [Related]

  • 9. Silver staining of nucleolar organizer regions in prostatic lesions.
    Ghazizadeh M, Sasaki Y, Oguro T, Aihara K.
    Histopathology; 1991 Oct; 19(4):369-72. PubMed ID: 1718838
    [Abstract] [Full Text] [Related]

  • 10. Argyrophilic nucleolar organizer regions in atypical adenomatous hyperplasias, prostatic intraepithelial neoplasias and prostatic neoplasms.
    Mukherjee J, Misra V, Gupta SC, Gupta AK, Tandon SP.
    Urol Int; 1997 Oct; 58(2):75-9. PubMed ID: 9096266
    [Abstract] [Full Text] [Related]

  • 11. Cytogenetic studies of prostatic cancer.
    Lundgren R.
    Scand J Urol Nephrol Suppl; 1991 Oct; 136():1-35. PubMed ID: 1871551
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [AGNOR analyses of prostate carcinomas of high and malignancy].
    Helpap B, Riede C.
    Verh Dtsch Ges Pathol; 1993 Oct; 77():93-7. PubMed ID: 7511310
    [Abstract] [Full Text] [Related]

  • 14. Progressive activity in latent prostate carcinoma defined by argyrophilic staining of the nucleolar organizer regions (AgNOR).
    Konishi N, Nakaoka S, Tsuzuki T, Kitahori Y, Nishii K, Kitamura M, Ohshima M, Hiasa Y.
    Pathol Int; 1994 Apr; 44(4):297-302. PubMed ID: 7519105
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.